Joseph R. Garlich
- Molecular Biology top 10%
- Oncology
- Pathology and Forensic Medicine top 10%
- Hematology top 10%
- Organic Chemistry
- Co-authors
- Donald L. DurdenRaymond J. BergeronShweta JoshiAlok R. SinghGuillermo A. MoralesNandini DeyPradip DeQiong Peng
- Topics
- PI3K/AKT/mTOR signaling in cancer (10 papers)Protein Degradation and Inhibitors (7 papers)Chronic Lymphocytic Leukemia Research (5 papers)
- Cited by
- HematologyGeneticsMolecular Biology
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Joseph R. Garlich
33 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 735
- Oncology 210
- Pathology and Forensic Medicine 140
- Hematology 140
- Organic Chemistry 131
Countries citing papers authored by Joseph R. Garlich
This map shows the geographic impact of Joseph R. Garlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph R. Garlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph R. Garlich more than expected).
Fields of papers citing papers by Joseph R. Garlich
This network shows the impact of papers produced by Joseph R. Garlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph R. Garlich. The network helps show where Joseph R. Garlich may publish in the future.
Co-authorship network of co-authors of Joseph R. Garlich
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph R. Garlich. A scholar is included among the top collaborators of Joseph R. Garlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph R. Garlich. Joseph R. Garlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 41 | |
| 3 | 98 | |
| 4 | 51 | |
| 5 | 23 | |
| 6 | 2 | |
| 7 | 21 | |
| 8 | 107 | |
| 9 | 1 | |
| 10 | 10 | |
| 11 | 5 | |
| 12 | 1 | |
| 13 | 230 | |
| 14 | Preclinical studies of a pan PI3K inhibitor (SF1126) in renal cell carcinoma | 1 |
| 15 | 73 | |
| 16 | 9 | |
| 17 | 24 | |
| 18 | 31 | |
| 19 | 53 | |
| 20 | 9 |
About Joseph R. Garlich
Joseph R. Garlich is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (10 papers), Protein Degradation and Inhibitors (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Hematology (140 citations), Genetics (115 citations) and Molecular Biology (735 citations). Joseph R. Garlich has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Donald L. Durden, Raymond J. Bergeron, Shweta Joshi, Alok R. Singh, Guillermo A. Morales, Nandini Dey, Pradip De, Qiong Peng, Yiling Lu and Neal J. Stolowich. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.